Pemetrexed decreases circulating S100A9-myeloid derived suppressor cells in patients with non-small cell lung cancer

被引：0
|
作者：
Feng, Po-Hao
Lee, Kang-Yun
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1404
引用
收藏
页数：3
相关论文
共 50 条
  • [21] High frequency of a circulating monocytic subpopulation of myeloid-derived suppressor cells predicts worst clinical outcome in untreated non-small lung cancer patients
    Vetsika, Eleni Kyriaki
    Koinis, Filippos
    Gioulmpasani, Marianthi
    Aggouraki, Despoina
    Koutoulaki, Anna
    Skalidaki, Eirini
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    BMC Cancer, 14 (1)
  • [23] The heterogeneity of circulating lung tumor cells from non-small cell lung cancer patients
    Kong, S. L.
    Tan, S. J.
    Lim, T. K. H.
    Poh, H. M.
    Yeo, T. Z. X.
    Liu, X.
    Chua, Y. W.
    Bhagat, A. A.
    Lim, W. T.
    Hillmer, A. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S80 - S80
  • [24] Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
    Lee, Jih-Hsiang
    Yu, Chong-Jen
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Lin, Yu-Lin
    Yang, Chih-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (05) : 338 - 344
  • [25] Role of Pemetrexed and Platinums Combination in Patients with Non-Small Cell Lung Cancer
    Chen, Manyin
    Shao, Wenlong
    He, Jianxing
    Wang, Daoyuan
    CURRENT DRUG TARGETS, 2010, 11 (01) : 29 - 36
  • [26] Culture of circulating tumour cells derived from non-small cell lung cancer.
    O'Byrne, Kenneth John
    Kapeleris, Joanna
    Kulasinghe, Arutha
    Warkiani, Majid E.
    O'Leary, Connor Gerard
    Ladwa, Rahul
    Vela, Ian
    Leo, Paul
    Sternes, Peter
    Punyadeera, Chamindie
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer
    Koinis, Filippos
    Vetsika, Eleni Kyriaki
    Aggouraki, Despoina
    Skalidaki, Eleftheria
    Koutoulaki, Anna
    Gkioulmpasani, Marianthi
    Georgoulias, Vassitis
    Kotsakis, Athanasios
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : 1263 - 1272
  • [28] The Prognostic Role of Myeloid-derived Suppressor Cells Related Markers in Peripheral Blood From Advanced Non-small Cell Lung Cancer Patients
    Sirera, R.
    Jantus-Lewintre, E.
    Caballero, E.
    Artigot, A.
    Sanmartin, E.
    Uso, M.
    Rosell, R.
    Gallach, S.
    Camps, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S632 - S632
  • [29] Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer
    de Goeje, Pauline L.
    Bezemer, Koen
    Heuvers, Marlies E.
    Dingemans, Anne-Marie C.
    Groen, Harry J. M.
    Smit, Egbert F.
    Hoogsteden, Henk C.
    Hendriks, Rudi W.
    Aerts, Joachim G. J. V.
    Hegmans, Joost P. J. J.
    ONCOIMMUNOLOGY, 2015, 4 (07): : 1 - 11
  • [30] Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer
    Li, Rui
    Dubinett, Steven M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S331 - S333
12345